IQVIA Gets CDSCO Panel Nod To conduct Phase III clinical Study of Lumateperone Dr. Divya Colin28 Dec 2024 6:30 PM ISTNew Delhi: IQVIA has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to...
NRX-101 First Antidepressant that Lowers Suicidality in Bipolar Depression, reveals research Dr. Kamal Kant Kohli5 Jun 2024 7:30 PM ISTNRX-101 is First Antidepressant that Lowers Suicidality in Bipolar Depression, confirms Double blind Controlled trial. NRx...
Medical Bulletin 4/August/2023 Isra Zaman4 Aug 2023 3:15 PM ISTHere are the top medical news of the day:Bipolar depression relapse risk reduced by modern antidepressantsTreatment with modern antidepressants may...
Bipolar depression relapse risk reduced by modern antidepressants Isra Zaman4 Aug 2023 9:00 AM ISTTreatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an...
Treatment-resistant depression improves with ketamine infusion: JAMA Dr. Kamal Kant Kohli20 Oct 2022 9:45 AM ISTUSA: According to a report published in JAMA Psychiatry, when treatment-resistant depression patients were compared to healthy controls, belief...
Ketamine to effectively reduce depression and suicidal thoughts Roshni Dhar11 Jan 2022 4:02 PM ISTDepression is a leading cause death globally, over 16 million people die globally due to depressive symptoms. Depression is known to greatly affect...
